Nelson, Van Denburg & Campbell Wealth Management Group, LLC Cassava Sciences Inc Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.42 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$18.44 - $26.41 $147 - $211	8 New	8 $0
Q2 2022 Aug 10, 2022	SELL	$17.22 - $38.47 $12,587 - $28,121	-731 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $26,878 - $66,455	731 New	731 $31,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$7.57 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$5.93 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$2.73 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$2.37 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$1.36 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $94.2M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account